• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于组织工程心脏瓣膜的新型混合支架的制造。

Fabrication of a novel hybrid scaffold for tissue engineered heart valve.

作者信息

Hong Hao, Dong Nianguo, Shi Jiawei, Chen Si, Guo Chao, Hu Ping, Qi Hongxu

机构信息

Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

出版信息

J Huazhong Univ Sci Technolog Med Sci. 2009 Oct;29(5):599-603. doi: 10.1007/s11596-009-0513-6. Epub 2009 Oct 11.

DOI:10.1007/s11596-009-0513-6
PMID:19821093
Abstract

The aim of this study was to fabricate biomatrix/polymer hybrid scaffolds using an electrospinning technique. Then tissue engineered heart valves were engineered by seeding mesenchymal stromal cells (MSCs) onto the scaffolds. The effects of the hybrid scaffolds on the proliferation of seed cells, formation of extracellular matrix and mechanical properties of tissue engineered heart valves were investigated. MSCs were obtained from rats. Porcine aortic heart valves were decellularized, coated with poly(3-hydroxybutyrate-co-4-hydroxybutyrate) using an electrospinning technique, and reseeded and cultured over a time period of 14 days. In control group, the decellularized valve scaffolds were reseeded and cultured over an equivalent time period. Specimens of each group were examined histologically (hematoxylin-eosin [HE] staining, immunohistostaining, and scanning electron microscopy), biochemically (DNA and 4-hydroxyproline) and mechanically. The results showed that recellularization was comparable to the specimens of hybrid scaffolds and controls. The specimens of hybrid scaffolds and controls revealed comparable amounts of cell mass and 4-hydroxyproline (P>0.05). However, the specimens of hybrid scaffolds showed a significant increase in mechanical strength, compared to the controls (P<0.05). This study demonstrated the superiority of the hybrid scaffolds to increase the mechanical strength of tissue engineered heart valves. And compared to the decellularized valve scaffolds, the hybrid scaffolds showed similar effects on the proliferation of MSCs and formation of extracellular matrix. It was believed that the hybrid scaffolds could be used for the construction of tissue engineered heart valves.

摘要

本研究的目的是使用静电纺丝技术制备生物基质/聚合物混合支架。然后通过将间充质基质细胞(MSCs)接种到支架上来构建组织工程心脏瓣膜。研究了混合支架对种子细胞增殖、细胞外基质形成以及组织工程心脏瓣膜力学性能的影响。MSCs取自大鼠。将猪主动脉心脏瓣膜去细胞化,采用静电纺丝技术用聚(3-羟基丁酸酯-共-4-羟基丁酸酯)包被,重新接种并培养14天。在对照组中,将去细胞化的瓣膜支架重新接种并在相同时间段内培养。对每组标本进行组织学检查(苏木精-伊红[HE]染色、免疫组织化学染色和扫描电子显微镜检查)、生化检查(DNA和4-羟基脯氨酸)以及力学检查。结果表明,再细胞化与混合支架和对照组的标本相当。混合支架和对照组的标本显示出相当的细胞量和4-羟基脯氨酸含量(P>0.05)。然而,与对照组相比,混合支架的标本在机械强度上有显著增加(P<0.05)。本研究证明了混合支架在提高组织工程心脏瓣膜机械强度方面的优越性。并且与去细胞化瓣膜支架相比,混合支架对MSCs增殖和细胞外基质形成的影响相似。据信,混合支架可用于构建组织工程心脏瓣膜。

相似文献

1
Fabrication of a novel hybrid scaffold for tissue engineered heart valve.用于组织工程心脏瓣膜的新型混合支架的制造。
J Huazhong Univ Sci Technolog Med Sci. 2009 Oct;29(5):599-603. doi: 10.1007/s11596-009-0513-6. Epub 2009 Oct 11.
2
Fabrication of a novel hybrid heart valve leaflet for tissue engineering: an in vitro study.用于组织工程的新型混合心脏瓣膜小叶的制造:一项体外研究。
Artif Organs. 2009 Jul;33(7):554-8. doi: 10.1111/j.1525-1594.2009.00742.x.
3
Fabrication of biomatrix/polymer hybrid scaffold for heart valve tissue engineering in vitro.用于体外心脏瓣膜组织工程的生物基质/聚合物混合支架的制备
ASAIO J. 2008 Nov-Dec;54(6):627-32. doi: 10.1097/MAT.0b013e31818965d3.
4
Modifying decellularized aortic valve scaffolds with stromal cell-derived factor-1α loaded proteolytically degradable hydrogel for recellularization and remodeling.用负载基质细胞衍生因子-1α的蛋白水解可降解水凝胶修饰去细胞主动脉瓣支架以进行再细胞化和重塑。
Acta Biomater. 2019 Apr 1;88:280-292. doi: 10.1016/j.actbio.2019.02.002. Epub 2019 Feb 2.
5
Mechanical and structural properties of a novel hybrid heart valve scaffold for tissue engineering.用于组织工程的新型混合心脏瓣膜支架的力学和结构特性
Artif Organs. 2004 Nov;28(11):971-9. doi: 10.1111/j.1525-1594.2004.00007.x.
6
[Experimental study on mechanical properties of decellularized porcine aortic valve and effects of precoating methods of biological scaffold on histocompatibility].[去细胞猪主动脉瓣力学性能及生物支架预涂层方法对组织相容性影响的实验研究]
Zhonghua Wai Ke Za Zhi. 2007 Aug 15;45(16):1128-31.
7
Engineering of a polymer layered bio-hybrid heart valve scaffold.聚合物层状生物杂交心脏瓣膜支架的工程设计。
Mater Sci Eng C Mater Biol Appl. 2015 Jun;51:263-73. doi: 10.1016/j.msec.2015.03.009. Epub 2015 Mar 11.
8
Enhancement of mesenchymal stem cell attachment to decellularized porcine aortic valve scaffold by in vitro coating with antibody against CD90: a preliminary study on antibody-modified tissue-engineered heart valve.通过体外包被抗CD90抗体增强间充质干细胞与去细胞猪主动脉瓣支架的附着:抗体修饰组织工程心脏瓣膜的初步研究
Tissue Eng Part A. 2009 Jan;15(1):1-11. doi: 10.1089/ten.tea.2008.0001.
9
Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.利用去细胞支架和内皮祖细胞构建组织工程心脏瓣膜。
Chin Med J (Engl). 2007 Apr 20;120(8):696-702.
10
Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study.
Cardiovasc Res. 2003 Dec 1;60(3):497-509. doi: 10.1016/j.cardiores.2003.09.002.

引用本文的文献

1
Recellularization of decellularized heart valves: Progress toward the tissue-engineered heart valve.去细胞心脏瓣膜的再细胞化:组织工程心脏瓣膜的进展。
J Tissue Eng. 2017 Aug 25;8:2041731417726327. doi: 10.1177/2041731417726327. eCollection 2017 Jan-Dec.
2
Tissue-engineered heart valve: future of cardiac surgery.组织工程心脏瓣膜:心脏外科手术的未来。
World J Surg. 2012 Jul;36(7):1581-91. doi: 10.1007/s00268-012-1535-y.

本文引用的文献

1
The use of acellular matrices for the tissue engineering of cardiac valves.脱细胞基质在心脏瓣膜组织工程中的应用。
Proc Inst Mech Eng H. 2008 Jan;222(1):129-43. doi: 10.1243/09544119JEIM230.
2
Biological scaffolds for heart valve tissue engineering.用于心脏瓣膜组织工程的生物支架
Methods Mol Med. 2007;140:309-17. doi: 10.1007/978-1-59745-443-8_17.
3
Proliferation of chondrocytes on porous poly(DL-lactide)/chitosan scaffolds.软骨细胞在多孔聚(DL-丙交酯)/壳聚糖支架上的增殖
Acta Biomater. 2008 Jan;4(1):76-87. doi: 10.1016/j.actbio.2007.06.010. Epub 2007 Aug 2.
4
Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices.使用去细胞异种或聚合物起始基质进行心脏瓣膜组织工程。
Philos Trans R Soc Lond B Biol Sci. 2007 Aug 29;362(1484):1505-12. doi: 10.1098/rstb.2007.2131.
5
Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft.在聚碳酸亚丙酯移植物上利用基因改造的骨髓间充质干细胞构建血管移植物。
Artif Organs. 2006 Dec;30(12):898-905. doi: 10.1111/j.1525-1594.2006.00322.x.
6
Living autologous heart valves engineered from human prenatally harvested progenitors.利用产前采集的人类祖细胞构建的活体自体心脏瓣膜。
Circulation. 2006 Jul 4;114(1 Suppl):I125-31. doi: 10.1161/CIRCULATIONAHA.105.001040.
7
PCL-PU composite vascular scaffold production for vascular tissue engineering: attachment, proliferation and bioactivity of human vascular endothelial cells.用于血管组织工程的聚己内酯-聚氨酯复合血管支架的制备:人血管内皮细胞的黏附、增殖及生物活性
Biomaterials. 2006 Jul;27(19):3608-16. doi: 10.1016/j.biomaterials.2006.02.025. Epub 2006 Mar 13.
8
Controlled fabrication of a biological vascular substitute.生物血管替代物的可控制造。
Biomaterials. 2006 Mar;27(7):1088-94. doi: 10.1016/j.biomaterials.2005.07.048. Epub 2005 Aug 29.
9
Performance of decellularized xenogeneic tissue in heart valve replacement.去细胞异种组织在心脏瓣膜置换中的性能。
Biomaterials. 2006 Jan;27(1):1-2. doi: 10.1016/j.biomaterials.2005.05.100.
10
Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study.
Cardiovasc Res. 2003 Dec 1;60(3):497-509. doi: 10.1016/j.cardiores.2003.09.002.